Clinical trial

Use of Bevacizumab in Trabeculectomy Surgery

NCT01166594

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-01

PhasePHASE4

Study timeline

Study start (unknown)2010-06-01Date precision: month

Registry last updated2023-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Optic Neuropathyunresolved

Fibrosisunresolved

Interventions

BevacizumabDRUG · verified · RxNorm: bevacizumab

ControlDRUG

Sponsors & collaborators

Sunnybrook Health Sciences Centrelead sponsor

Glaucoma Research Society of Canadacollaborator

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01166594 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.